UPDATE 2-U.S. Treasury tackles tax inversions; Pfizer-Allergan in spotlight
WASHINGTON, April 4 (Reuters) - The U.S. Treasury Department on Monday took new steps to curb tax-avoiding "inversion" deals in which a U.S. company reincorporates overseas after purchasing a foreign company, and shares of Allergan Plc, the linchpin of a big pending inversion deal, slumped. [Source]
Publication Date:Origin: us.feedsportal.com
Category: industrialsSector
Topics: company, Treasury, slumped, inversion, pending, linchpin, Allergan, shares, foreign, purchasing, overseas, reincorporates, which, deals, "inversion", tax-avoiding, steps, Department, (Reuters), April, WASHINGTON, spotlight, Pfizer-Allergan, inversions;, tackles, UPDATE